TY - JOUR
T1 - Evaluating surgeon attitudes towards the safety and efficacy of portal vein occlusion and associating liver partition and portal vein ligation
T2 - A report of the MALINSA survey
AU - Day, Ryan W.
AU - Conrad, Claudius
AU - Vauthey, Jean Nicolas
AU - Aloia, Thomas A.
N1 - Publisher Copyright:
© 2015 International Hepato-Pancreato-Biliary Association.
PY - 2015/10/1
Y1 - 2015/10/1
N2 - Background Various techniques, including portal vein embolization (PVE), contralateral portal vein ligation (PVL) and associating liver partition and portal vein ligation (ALPPS), are being used to augment the future liver remnant (FLR) volume in preparation for a major hepatectomy. The present study aims to survey and document the availability, variation, utilization and attitudes toward these techniques across centres in North and South America. Methods A descriptive, 20-question survey was developed and internally validated with expert review. The survey was distributed to 115 centres in North and South America. Results Of the 115 centres, 54 institutions (47%) returned the surveys. Regarding the question of which modality was most likely to produce adequate hypertrophy, the respondents were equally distributed (ALPPS, 37%; PVE, 35%; equal, 22%). The procedure that respondents judged the safest to achieve liver hypertrophy was PVE (82%). Institutions with capability to extended PVE to segment IV rated the likelihood of PVE technical success (6.2 versus 8.5, P = 0.012) and likelihood of subsequent hypertrophy (5.6 versus 7.8, P = 0.011) higher than institutions without this capability. Although the use of modern embolic materials was associated with a likelihood of successful PVE (P = 0.032), only 49% of respondents who performed PVE used embolic microspheres. Conclusions There exists significant variability in utilization of and attitudes towards the available techniques for FLR volume augmentation. Penetration of best practice techniques for PVE is lacking, and may be contributing towards disappointment with PVE efficacy, potentially motivating the utilization of the riskier ALPPS procedure.
AB - Background Various techniques, including portal vein embolization (PVE), contralateral portal vein ligation (PVL) and associating liver partition and portal vein ligation (ALPPS), are being used to augment the future liver remnant (FLR) volume in preparation for a major hepatectomy. The present study aims to survey and document the availability, variation, utilization and attitudes toward these techniques across centres in North and South America. Methods A descriptive, 20-question survey was developed and internally validated with expert review. The survey was distributed to 115 centres in North and South America. Results Of the 115 centres, 54 institutions (47%) returned the surveys. Regarding the question of which modality was most likely to produce adequate hypertrophy, the respondents were equally distributed (ALPPS, 37%; PVE, 35%; equal, 22%). The procedure that respondents judged the safest to achieve liver hypertrophy was PVE (82%). Institutions with capability to extended PVE to segment IV rated the likelihood of PVE technical success (6.2 versus 8.5, P = 0.012) and likelihood of subsequent hypertrophy (5.6 versus 7.8, P = 0.011) higher than institutions without this capability. Although the use of modern embolic materials was associated with a likelihood of successful PVE (P = 0.032), only 49% of respondents who performed PVE used embolic microspheres. Conclusions There exists significant variability in utilization of and attitudes towards the available techniques for FLR volume augmentation. Penetration of best practice techniques for PVE is lacking, and may be contributing towards disappointment with PVE efficacy, potentially motivating the utilization of the riskier ALPPS procedure.
UR - http://www.scopus.com/inward/record.url?scp=84941874626&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84941874626&partnerID=8YFLogxK
U2 - 10.1111/hpb.12439
DO - 10.1111/hpb.12439
M3 - Article
C2 - 26255813
AN - SCOPUS:84941874626
SN - 1365-182X
VL - 17
SP - 936
EP - 941
JO - HPB
JF - HPB
IS - 10
ER -